Prelude Capital Management’s Nu Skin NUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $69.7K | Buy |
13,200
+887
| +7% | +$5.67K | 0.01% | 1151 |
|
|
2026
Q1 | $89.6K | Sell |
12,313
-5,264
| -30% | -$47.7K | 0.01% | 1068 |
|
|
2025
Q4 | $169K | Buy |
17,577
+6,173
| +54% | +$63.9K | 0.01% | 1096 |
|
|
2025
Q3 | $139K | Sell |
11,404
-96
| -0.8% | -$1.01K | 0.01% | 1011 |
|
|
2025
Q2 | $91.9K | Sell |
11,500
-7,600
| -40% | -$53.4K | 0.01% | 924 |
|
|
2025
Q1 | $139K | Sell |
19,100
-4,300
| -18% | -$31.3K | 0.01% | 998 |
|
|
2024
Q4 | $161K | Sell |
23,400
-3,100
| -12% | -$21.3K | 0.01% | 1036 |
|
|
2024
Q3 | $195K | Buy |
+26,500
| New | +$248K | 0.01% | 1075 |
|
|
2024
Q2 | – | Sell |
-23,604
| Closed | -$326K | – | 1407 |
|
|
2024
Q1 | $326K | Buy |
23,604
+13,004
| +123% | +$203K | 0.02% | 851 |
|
|
2023
Q4 | $206K | Buy |
+10,600
| New | +$196K | 0.01% | 930 |
|
|
2020
Q3 | – | Sell |
-5,647
| Closed | -$216K | – | 2195 |
|
|
2020
Q2 | $216K | Buy |
5,647
+4,866
| +623% | +$156K | 0.01% | 718 |
|
|
2020
Q1 | $17K | Sell |
781
-567
| -42% | -$17.1K | ﹤0.01% | 1025 |
|
|
2019
Q4 | $55K | Buy |
+1,348
| New | +$55K | ﹤0.01% | 1303 |
|
|
2019
Q1 | – | Sell |
-277
| Closed | -$17K | – | 2042 |
|
|
2018
Q4 | $17K | Buy |
+277
| New | +$18.7K | ﹤0.01% | 1271 |
|
|
2018
Q2 | – | Sell |
-860
| Closed | -$63K | – | 1859 |
|
|
2018
Q1 | $63K | Buy |
860
+44
| +5% | +$3.12K | ﹤0.01% | 1002 |
|
|
2017
Q4 | $56K | Buy |
+816
| New | +$52.8K | ﹤0.01% | 915 |
|
|
2016
Q4 | – | Sell |
-523
| Closed | -$34K | – | 1709 |
|
|
2016
Q3 | $34K | Sell |
523
-447
| -46% | -$25.1K | ﹤0.01% | 1178 |
|
|
2016
Q2 | $45K | Buy |
+970
| New | +$39.1K | 0.01% | 1052 |
|
|
2016
Q1 | – | Sell |
-2,930
| Closed | -$111K | – | 1437 |
|
|
2015
Q4 | $111K | Buy |
2,930
+1,130
| +63% | +$41.6K | 0.02% | 781 |
|
|
2015
Q3 | $74K | Buy |
1,800
+1,500
| +500% | +$64.4K | 0.01% | 930 |
|
|
2015
Q2 | $14K | Sell |
300
-400
| -57% | -$21.6K | ﹤0.01% | 1520 |
|
|
2015
Q1 | $42K | Buy |
700
+100
| +17% | +$5.09K | 0.01% | 1398 |
|
|
2014
Q4 | $26K | Buy |
+600
| New | +$26.5K | ﹤0.01% | 1662 |
|
|
2014
Q3 | – | Sell |
-3,250
| Closed | -$240K | – | 2044 |
|
|
2014
Q2 | $240K | Buy |
3,250
+1,625
| +100% | +$128K | 0.03% | 672 |
|
|
2014
Q1 | $135K | Buy |
1,625
+72
| +5% | +$6.33K | 0.02% | 877 |
|
|
2013
Q4 | $215K | Buy |
1,553
+612
| +65% | +$72.1K | 0.04% | 599 |
|
|
2013
Q3 | $90K | Sell |
941
-1,359
| -59% | -$115K | 0.01% | 795 |
|
|
2013
Q2 | $141K | Buy |
+2,300
| New | +$128K | 0.03% | 522 |
|
Other funds holding NUS
CAS
PGCM
Prelude Capital Management's NUS Position: Q2 2026 in Review
Prelude Capital Management increased its Nu Skin (NUS) stake by 7.2% in Q2 2026, buying an estimated $5.67K and bringing the position to 13,200 shares worth $69.7K. The position accounts for 0.01% of the portfolio, ranked #1151.
Prelude Capital Management first reported a position in NUS in Q2 2013 and has held it in 28 quarters since. The position peaked at $326K in Q1 2024. 162 funds tracked by Wall St. Rank hold NUS as of Q2 2026.
- Prelude Capital Management held 13,200 shares of Nu Skin worth $69.7K as of Q2 2026.
- Prelude Capital Management bought 887 Nu Skin shares in Q2 2026, an estimated $5.67K.
- Nu Skin made up 0.01% of Prelude Capital Management's portfolio in Q2 2026, its #1151 holding.
- Prelude Capital Management first reported a position in Nu Skin in Q2 2013 and has held it in 28 quarters since.
- Prelude Capital Management's Nu Skin position peaked at $326K in Q1 2024.
- 162 funds tracked by Wall St. Rank held Nu Skin as of Q2 2026.
Based on Prelude Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.